Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Human Papillomavirus (HPV) Testing

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More

  • Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases

    ... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More

  • Non-Infectious Macular Edema Treatment

    ... reach US$25.0 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Anti-VEGF Drug, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach ... Read More

  • Nursing Breast Pads

    ... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Reusable Nursing Breast Pads, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$220.4 ... Read More

  • Orthodontic Services

    ... CAGR of 11.5% over the analysis period 2023-2030. Removable Orthodontic Services, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$7.7 Billion by the end of the ... Read More

  • Soft Tissue Allografts

    ... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More

  • Women's Health Rehabilitation Products

    ... 2030, growing at a CAGR of 1.2% over the analysis period 2023-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$731.9 Million by ... Read More

  • Male Infertility

    ... CAGR of 5.8% over the analysis period 2023-2030. DNA Fragmentation Technique, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.6 Billion by the end of the ... Read More

  • Hyaluronic Acid-based Dermal Fillers

    ... 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Single Phase Hyaluronic Acid-based Dermal Fillers, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach ... Read More

  • Anxiolytics

    ... 4.6% over the analysis period 2023-2030. The U.S. Market is Estimated at US$250.6 Million While China is Forecast to Grow at 7.1% CAGR The Anxiolytics market in the U.S. is estimated at US$250.6 Million in ... Read More

  • Disruptive Behavior Disorder (DBD) Treatment

    ... Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Oppositional Defiant Disorder, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$19.2 ... Read More

  • Interventional Oncology Devices

    ... at a CAGR of 6.3% over the analysis period 2023-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.4 Billion by the end of ... Read More

  • Ophthalmic Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030

    ... Cataracts, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing ... Read More

  • Neurovascular Devices / Interventional Neurology

    ... is expected to reach US$6.1 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is expected to ... Read More

  • Oncology Information Systems

    ... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by ... Read More

  • Online Sex Toys

    ... by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.5 Billion by ... Read More

  • Immunotherapy Drugs

    ... at a CAGR of 9.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of ... Read More

  • Peptic Ulcer Drugs

    ... by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.6 Billion by the ... Read More

  • Knee Braces

    ... at a CAGR of 5.1% over the analysis period 2023-2030. Functional, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$875.4 Million by the end of the ... Read More

  • Foot and Ankle Braces

    ... reach US$1.5 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. The U.S. Market is Estimated at US$244.8 Million While China is Forecast to Grow at 10.5% CAGR The Foot ... Read More

  • Anti-Allergy Drugs

    ... at a CAGR of 7.1% over the analysis period 2023-2030. Pharmacies Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$35.4 Billion by the end of ... Read More

  • Skin Allergy Therapeutics

    ... by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. The U.S. Market is Estimated at US$472.4 Million While China is Forecast to Grow at 8.3% CAGR The Skin Allergy Therapeutics market ... Read More

  • Glaucoma Surgery Devices

    ... by 2030, growing at a CAGR of 20.7% over the analysis period 2023-2030. Traditional Surgery Method, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$3.1 Billion ... Read More

  • Penile Implants

    ... at a CAGR of 4.3% over the analysis period 2023-2030. Inflatable Implant, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$557.9 Million by the end of ... Read More

  • Pigmentation Disorders Treatment

    ... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$4.5 Billion by ... Read More

Cookie Settings